A detailed history of Syon Capital LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Syon Capital LLC holds 17,674 shares of ABBV stock, worth $3.18 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
17,674
Previous 17,200 2.76%
Holding current value
$3.18 Million
Previous $2.95 Billion 18.31%
% of portfolio
0.31%
Previous 0.27%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$163.84 - $199.33 $77,660 - $94,482
474 Added 2.76%
17,674 $3.49 Billion
Q2 2024

Aug 13, 2024

SELL
$154.79 - $180.76 $115,937 - $135,389
-749 Reduced 4.17%
17,200 $2.95 Billion
Q1 2024

May 14, 2024

BUY
$159.82 - $182.1 $258,109 - $294,091
1,615 Added 9.89%
17,949 $3.27 Billion
Q4 2023

Feb 02, 2024

BUY
$137.6 - $154.97 $682,771 - $768,961
4,962 Added 43.63%
16,334 $2.53 Billion
Q3 2023

Nov 03, 2023

BUY
$133.59 - $154.65 $1.52 Million - $1.76 Million
11,372 New
11,372 $1.7 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Syon Capital LLC Portfolio

Follow Syon Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Syon Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Syon Capital LLC with notifications on news.